skin rashes and alopecia. 1 In the era of targeted therapy in RA, there are now more alternatives for biologic agents than traditional DMARDs. Leflunomide, like methotrexate, has a role in RA ...

Enhanced treatment strategies which effectively meet clinical outcomes for RA patients and are economically viable are essential in current practice. Based upon the evidence, leflunomide and ...

rheumatology.medfac.leidenuniv.nl Leflunomide is a selective inhibitor of de novo pyrimidine synthesis. In phase II and III clinical trials of active rheumatoid arthritis, leflunomide was shown to ...

Background Leflunomide is a new disease-modifying antirheumatic drug (DMARD) approved for the treatment of active RA as an alternative to methotrexate (MTX) therapy. Infliximab is approved for the ...

This study investigated, for the first time, the efficacy and safety profile of leflunomide 20mg daily in ambulatory RA patients in typical settings. This is of importance, as the existing body of ...

The disease-modifying antirheumatic drugs, such as methotrexate and leflunomide (Arava) prescribed for RA are not appropriate for this type of arthritis. A physician who is familiar with your clinical ...